Acute Effects of Levosimendan and Dobutamine on QRS Duration in Patients with Heart Failure

Creative Commons License

YONTAR O. C., YILMAZ M. B., YALTA K., ERDEM A., TANDOĞAN İ.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA, cilt.95, sa.6, ss.738-742, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 95 Sayı: 6
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1590/s0066-782x2010005000143
  • Dergi Adı: ARQUIVOS BRASILEIROS DE CARDIOLOGIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.738-742
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Background: Levosimendan is a novel inotropic agent that enhances cardiac contractility without increasing cellular calcium intake, so that it is not supposed to cause intracellular calcium overload and related arrhythmias. In patients with heart failure, prolonged QRS duration is associated with increased risk of mortality and sudden cardiac death. Structural changes in the left ventricle may lead to asynchronous contraction, causing conduction delay and a prolonged QRS on the surface electrocardiogram.